| 101 |
29779937 | Estrogen receptor positive breast tumors resist chemotherapy by the overexpression of P53 in Cancer Stem Cells. | 2018 Jun |
1 |
| 102 |
29980405 | Introduction of WT-TP53 into pancreatic cancer cells alters sensitivity to chemotherapeutic drugs, targeted therapeutics and nutraceuticals. | 2018 Aug |
1 |
| 103 |
30103170 | Metronomic oral doxorubicin in combination of Chk1 inhibitor MK-8776 for p53-deficient breast cancer treatment. | 2018 Nov |
5 |
| 104 |
30124118 | TP53-dependence on the effect of doxorubicin and Src inhibitor combination therapy. | 2018 Aug |
5 |
| 105 |
30198376 | P53 enhances apoptosis induced by doxorubicin only under conditions of severe DNA damage. | 2018 |
4 |
| 106 |
30217455 | 4-Hydroxybenzoic acid (4-HBA) enhances the sensitivity of human breast cancer cells to adriamycin as a specific HDAC6 inhibitor by promoting HIPK2/p53 pathway. | 2018 Oct 12 |
2 |
| 107 |
30245854 | KLLN-mediated DNA damage-induced apoptosis is associated with regulation of p53 phosphorylation and acetylation in breast cancer cells. | 2018 |
2 |
| 108 |
30257423 | Protective Roles of Thymoquinone Nanoformulations: Potential Nanonutraceuticals in Human Diseases. | 2018 Sep 25 |
1 |
| 109 |
30274043 | In vitro evaluation of a biomaterial-based anticancer drug delivery system as an alternative to conventional post-surgery bone cancer treatment. | 2018 Dec 1 |
1 |
| 110 |
30285883 | Breast cancer survival predicted by TP53 mutation status differs markedly depending on treatment. | 2018 Oct 1 |
1 |
| 111 |
30387987 | In Situ Proapoptotic Peptide-Generating Rapeseed Protein-Based Nanocomplexes Synergize Chemotherapy for Cathepsin-B Overexpressing Breast Cancer. | 2018 Dec 5 |
1 |
| 112 |
30405800 | Low dose dinaciclib enhances doxorubicin-induced senescence in myeloma RPMI8226 cells by transformation of the p21 and p16 pathways. | 2018 Nov |
2 |
| 113 |
30488759 | Mathematical model identifies effective P53 accumulation with target gene binding affinity in DNA damage response for cell fate decision. | 2018 |
3 |
| 114 |
30507074 | Comparative transcriptomic analysis reveals adriamycin-induced apoptosis via p53 signaling pathway in retinal pigment epithelial cells. | 2018 Dec. |
1 |
| 115 |
32254384 | A synergistic polyphosphoester-based co-delivery system of the anticancer drug doxorubicin and the tumor suppressor gene p53 for lung cancer therapy. | 2018 May 28 |
3 |
| 116 |
27617579 | FKBP12 enhances sensitivity to chemotherapy-induced cancer cell apoptosis by inhibiting MDM2. | 2017 Mar 23 |
2 |
| 117 |
27770912 | Biocompatible cationic pullulan-g-desoxycholic acid-g-PEI micelles used to co-deliver drug and gene for cancer therapy. | 2017 Jan 1 |
2 |
| 118 |
27834950 | The novel p53 target TNFAIP8 variant 2 is increased in cancer and offsets p53-dependent tumor suppression. | 2017 Jan |
2 |
| 119 |
27836734 | Doxorubicin anti-tumor mechanisms include Hsp60 post-translational modifications leading to the Hsp60/p53 complex dissociation and instauration of replicative senescence. | 2017 Jan 28 |
1 |
| 120 |
27866093 | NSCA-1-a novel N-substituted coumalamide derivative-increases Adriamycin sensitivity in HepG2/adriamycin cells through modulating Akt/GSK-3β signaling and p53-dependant apoptotic pathway. | 2017 Jan |
2 |
| 121 |
27888811 | The role of p53 in cancer drug resistance and targeted chemotherapy. | 2017 Jan 31 |
1 |
| 122 |
28052008 | Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cells to doxorubicin. | 2017 Jan 31 |
1 |
| 123 |
28152424 | EPSIN 3, A Novel p53 Target, Regulates the Apoptotic Pathway and Gastric Carcinogenesis. | 2017 Mar |
3 |
| 124 |
28163043 | p53 Modulates the Fate of Cardiac Progenitor Cells Ex Vivo and in the Diabetic Heart In Vivo. | 2017 Feb |
1 |
| 125 |
28191463 | Substrate Stiffness Influences Doxorubicin-Induced p53 Activation via ROCK2 Expression. | 2017 |
4 |
| 126 |
28229963 | Constitutively activated ERK sensitizes cancer cells to doxorubicin: Involvement of p53-EGFR-ERK pathway. | 2017 Mar |
1 |
| 127 |
28232385 | The Cytidine Deaminase APOBEC3 Family Is Subject to Transcriptional Regulation by p53. | 2017 Jun |
1 |
| 128 |
28264987 | Nuclear retention of the lncRNA SNHG1 by doxorubicin attenuates hnRNPC-p53 protein interactions. | 2017 Apr |
7 |
| 129 |
28423695 | NDRG2 promotes adriamycin sensitivity through a Bad/p53 complex at the mitochondria in breast cancer. | 2017 Apr 25 |
1 |
| 130 |
28450532 | P53-miR-191-SOX4 regulatory loop affects apoptosis in breast cancer. | 2017 Aug |
2 |
| 131 |
28476801 | Azacytidine-induced Chemosensitivity to Doxorubicin in Human Breast Cancer MCF7 Cells. | 2017 May |
2 |
| 132 |
28498637 | β2-AR activation induces chemoresistance by modulating p53 acetylation through upregulating Sirt1 in cervical cancer cells. | 2017 Jul |
3 |
| 133 |
28528452 | Tumor suppressor protein p53 exerts negative transcriptional regulation on human sodium iodide symporter gene expression in breast cancer. | 2017 Aug |
1 |
| 134 |
28580174 | Effects of concomitant inactivation of p53 and pRb on response to doxorubicin treatment in breast cancer cell lines. | 2017 |
5 |
| 135 |
28608259 | JS-K, a GST-activated nitric oxide donor prodrug, enhances chemo-sensitivity in renal carcinoma cells and prevents cardiac myocytes toxicity induced by Doxorubicin. | 2017 Aug |
5 |
| 136 |
28628491 | Calcein-acetoxymethy ester enhances the antitumor effects of doxorubicin in nonsmall cell lung cancer by regulating the TopBP1/p53RR pathway. | 2017 Sep |
4 |
| 137 |
28653879 | TP53 alteration determines the combinational cytotoxic effect of doxorubicin and an antioxidant NAC. | 2017 Jun |
9 |
| 138 |
28655792 | Inhibiting p53 Acetylation Reduces Cancer Chemotoxicity. | 2017 Aug 15 |
1 |
| 139 |
28656004 | Berberine Reverses Hypoxia-induced Chemoresistance in Breast Cancer through the Inhibition of AMPK- HIF-1α. | 2017 |
1 |
| 140 |
28658321 | Effect of the p53-tristetraprolin-stathmin-1 pathway on trophoblasts at maternal-fetal interface. | 2017 |
1 |
| 141 |
28677808 | A novel engineered interferon-α hybrid molecule increases anticancer efficacy of doxorubicin in breast cancer chemotherapy. | 2017 Sep |
1 |
| 142 |
28684738 | Mechanistic clues to the protective effect of chrysin against doxorubicin-induced cardiomyopathy: Plausible roles of p53, MAPK and AKT pathways. | 2017 Jul 6 |
1 |
| 143 |
28714518 | Regulation of tubular recycling endosome biogenesis by the p53-MICALL1 pathway. | 2017 Aug |
3 |
| 144 |
28760703 | Berberine-induced cardioprotection and Sirt3 modulation in doxorubicin-treated H9c2 cardiomyoblasts. | 2017 Nov |
1 |
| 145 |
28791403 | Complex analysis of the TP53 tumor suppressor in mantle cell and diffuse large B-cell lymphomas. | 2017 Oct |
1 |
| 146 |
28837147 | Doxorubicin upregulates CXCR4 via miR-200c/ZEB1-dependent mechanism in human cardiac mesenchymal progenitor cells. | 2017 Aug 24 |
1 |
| 147 |
28915555 | Identification of a p53-repressed gene module in breast cancer cells. | 2017 Aug 22 |
1 |
| 148 |
28937626 | Aspalathin Reverts Doxorubicin-Induced Cardiotoxicity through Increased Autophagy and Decreased Expression of p53/mTOR/p62 Signaling. | 2017 Sep 22 |
2 |
| 149 |
28945070 | Inhibition of Thioredoxin Reductase by Targeted Selenopolymeric Nanocarriers Synergizes the Therapeutic Efficacy of Doxorubicin in MCF7 Human Breast Cancer Cells. | 2017 Oct 25 |
1 |
| 150 |
29021323 | Pathologic Stimulus Determines Lineage Commitment of Cardiac C-kit+ Cells. | 2017 Dec 12 |
2 |